↓ Skip to main content

Cochrane Database of Systematic Reviews

Galantamine for Alzheimer's disease and mild cognitive impairment

Overview of attention for article published in Cochrane database of systematic reviews, January 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
6 tweeters
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
299 Dimensions

Readers on

mendeley
251 Mendeley
citeulike
1 CiteULike
Title
Galantamine for Alzheimer's disease and mild cognitive impairment
Published in
Cochrane database of systematic reviews, January 2006
DOI 10.1002/14651858.cd001747.pub3
Pubmed ID
Authors

Clement Loy, Lon Schneider

Abstract

Galantamine is a specific, competitive, and reversible acetylcholinesterase inhibitor.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 251 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
United Kingdom 2 <1%
Brazil 1 <1%
Ireland 1 <1%
France 1 <1%
Belgium 1 <1%
Singapore 1 <1%
Japan 1 <1%
Spain 1 <1%
Other 0 0%
Unknown 240 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 36 14%
Student > Ph. D. Student 30 12%
Student > Bachelor 30 12%
Student > Master 25 10%
Other 19 8%
Other 53 21%
Unknown 58 23%
Readers by discipline Count As %
Medicine and Dentistry 67 27%
Psychology 19 8%
Pharmacology, Toxicology and Pharmaceutical Science 17 7%
Biochemistry, Genetics and Molecular Biology 14 6%
Agricultural and Biological Sciences 13 5%
Other 59 24%
Unknown 62 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2022.
All research outputs
#5,435,788
of 22,741,406 outputs
Outputs from Cochrane database of systematic reviews
#7,271
of 12,315 outputs
Outputs of similar age
#29,671
of 154,530 outputs
Outputs of similar age from Cochrane database of systematic reviews
#22
of 57 outputs
Altmetric has tracked 22,741,406 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,315 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 154,530 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.